AC
VRCA icon

Armistice Capital’s Verrica Pharmaceuticals VRCA Stock Holding History

Armistice Capital’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.74M Sell
518,181
-600,744
-54% -$3.85M 0.05% 146
2025
Q4 		$9.3M Buy
1,118,925
+479,732
+75% +$2.66M 0.11% 105
2025
Q3 		$2.75M Sell
639,193
-248,941
-28% -$1.5M 0.04% 137
2025
Q2 		$4.71M Buy
888,134
+31,394
+4% +$169K 0.08% 101
2025
Q1 		$3.79M Sell
856,740
-35,360
-4% -$229K 0.06% 125
2024
Q4 		$6.24M Buy
+892,100
New +$9.81M 0.09% 117

Other funds holding VRCA

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Armistice Capital's VRCA Position: Q1 2026 in Review

Armistice Capital reduced its Verrica Pharmaceuticals (VRCA) stake by 54% in Q1 2026, selling an estimated $3.85M and leaving 518,181 shares worth $2.74M. The position accounts for 0.05% of the portfolio, ranked #146.

Armistice Capital first reported a position in VRCA in Q4 2024 and has held it in 6 quarters since. The position peaked at $9.3M in Q4 2025. 39 funds tracked by Wall St. Rank hold VRCA as of Q1 2026.

  • Armistice Capital held 518,181 shares of Verrica Pharmaceuticals worth $2.74M as of Q1 2026.
  • Armistice Capital sold 600,744 Verrica Pharmaceuticals shares in Q1 2026, an estimated $3.85M.
  • Verrica Pharmaceuticals made up 0.05% of Armistice Capital's portfolio in Q1 2026, its #146 holding.
  • Armistice Capital first reported a position in Verrica Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Armistice Capital's Verrica Pharmaceuticals position peaked at $9.3M in Q4 2025.
  • 39 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q1 2026.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.